Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.
about
The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genesCloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell lineCellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleusStructure and expression of the human immunoglobulin lambda genesTwo newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cellsStable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptor.The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombinationSmall compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myelomaThe immunoglobulin-like modules Cepsilon3 and alpha2 are the minimal units necessary for human IgE-FcepsilonRI interaction.Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell linesTargeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell linesInterleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.In vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells.T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.Proteomic changes during B cell maturation: 2D-DIGE approach.Density gradient separation of lymphoid cells adhering to protein-A-containing staphylococci.HLXB9 gene expression, and nuclear location during in vitro neuronal differentiation in the SK-N-BE neuroblastoma cell line.Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone DiseaseMorphologic and functional characteristics of long-term cultures of murine myeloma cells.In vitro culture of primary plasmacytomas requires stromal cell feeder layers.Antibody producing human-human hybridomas. II. Derivation and characterization of an antibody specific for human leukemia cells.Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificityMultiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide.Decursin and Doxorubicin Are in Synergy for the Induction of Apoptosis via STAT3 and/or mTOR Pathways in Human Multiple Myeloma Cells.Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3On the expression and regulation of 5-lipoxygenase in human lymphocytes.Primary bioassay of human myeloma stem cells.Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction.Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders.High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma.Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomasConstruction and testing of mouse--human heteromyelomas for human monoclonal antibody production.Expression of a biologically active fragment of human IgE epsilon chain in Escherichia coli.Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man.Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodiesEBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry.Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models.
P2860
Q24556502-4D0B3CEB-842C-4AFB-BE7E-5EACDDDEB09AQ24628965-899631D4-9BAC-48E2-9443-5E6215F7B0F5Q24676791-462C7F39-790B-491E-B50D-C0C33CF92AD0Q24682829-F7CD7945-BD44-4B04-9229-FD5518E2AF68Q24685660-D5CDF495-4C63-4A37-AE62-BBBB684EDAACQ27637682-84D6BF0C-5562-4E16-9F71-65ED27A9DF7FQ28271930-145AFA5D-0803-49EC-A278-A7DE3FA97A3DQ28478936-E12D95B9-1665-44F7-8D5A-9EB568749525Q33852820-462FC063-8468-47A8-AFE3-F6B8DF9648D0Q34072709-FB874636-B65F-4B91-B718-60926B87277AQ34081748-0EA5592F-F127-41C1-9501-487D2FFBFB7CQ34194873-C5797369-AE54-4E4A-BF92-85388380879CQ34202885-D8A766BD-2736-479B-B35D-351794F1B9CEQ34712334-57AECAD4-DB8C-4FC2-9DB3-394E08032EDBQ35035757-BB534875-B2DB-48D3-B6F0-B647044777CCQ35119853-B34E6106-2CDE-45E0-A5BC-358538094E53Q35227841-92653AC4-BE6D-41F3-9679-1E4C8CD06AEFQ35824530-F92BEF4F-E007-4358-8FAA-ACA354191920Q35938169-EA0398E2-E4E9-4DB4-BFD6-1C2D02770B4BQ36011988-B3F12378-0066-4A98-AB86-93DB6C57EDF7Q36078288-7F1A277D-5FC9-4B03-A4D6-DCFC6E7616E0Q36149289-3B282E2D-217E-4139-A82D-E7A1FF08D360Q36348484-9BB8E10B-604F-4C6A-A4AF-83E788D0E5B2Q36406833-9ABD770C-5861-4CF5-8C94-548AE9B17196Q36640589-EF75F87B-F889-431A-9B6E-2575531C7036Q36933281-8936FBF3-D614-47C5-825E-57CCA20779F5Q36952838-B8867EF9-E640-4827-815C-A3C64363B71FQ36959306-5CDC80AF-D106-4CA9-8B73-AC75F9ED6BF2Q37047438-99E794B2-AE45-4D24-9DC8-2B9A28F9A420Q37111633-B4252190-13B6-452A-814E-9385E808F18EQ37344763-89F43481-29A1-49BC-ACE1-0F1ACB6699FEQ37414173-837B0BB3-3797-472F-9062-2230BCAA1F46Q37457354-F3BDDBFF-4369-440D-B5DE-AA26080CCDEBQ37509769-4A8D5A9A-B271-44FC-A013-CA8EBFEEDE50Q37565432-FBBA43A8-3D6A-433A-9748-A9CF0A905334Q37601779-72E26A99-7028-4FE8-9122-88DC945E2515Q37680814-9ABF3B0D-BFB5-4D37-8B7A-54662BA503BEQ38644507-DBB8CFCE-F6E0-4D71-B233-78C41B346B46Q38725959-0BF310E2-68C7-477E-AF04-77068AE9E8FCQ38743088-D9130E73-F0CE-411F-916B-F0C47889DAB9
P2860
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh-hant
name
Established immunoglobulin pro ...... s from an IgE myeloma patient.
@en
Established immunoglobulin producing myeloma
@nl
type
label
Established immunoglobulin pro ...... s from an IgE myeloma patient.
@en
Established immunoglobulin producing myeloma
@nl
prefLabel
Established immunoglobulin pro ...... s from an IgE myeloma patient.
@en
Established immunoglobulin producing myeloma
@nl
P2093
P4510
P1476
Established immunoglobulin pro ...... s from an IgE myeloma patient.
@en
P2093
P304
P577
1970-10-01T00:00:00Z